Medicinal Chemistry of Anticancer Drugs 2008
DOI: 10.1016/b978-0-444-52824-7.00009-3
|View full text |Cite
|
Sign up to set email alerts
|

Drugs That Inhibit Signalling Pathways for Tumor Cell Growth and Proliferation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 117 publications
0
7
0
Order By: Relevance
“…In this study, serine/threonine-protein kinase (SPK) was identified in H. longicornis saliva and this could constitute substantial functional implications given the key role of protein kinases (PTKs) in diverse biological activities. Serine/threonine-protein kinase is a type of PTK that orchestrates the regulation of proteins’ biological activities by phosphorylating the hydroxy group of serine and threonine, thus triggering a conformational change from an inactive to an active form of a protein ( Avendaño and Menéndez, 2008 ). Of note, many salivary peptides/proteins could affect the same host cell population (functional redundancy), and likewise, one salivary peptide/protein could target more than one host cell population (pluripotency) ( Aounallah et al., 2020 ), and these activities could be championed by the presence of serine/threonine-protein kinase.…”
Section: Discussionmentioning
confidence: 99%
“…In this study, serine/threonine-protein kinase (SPK) was identified in H. longicornis saliva and this could constitute substantial functional implications given the key role of protein kinases (PTKs) in diverse biological activities. Serine/threonine-protein kinase is a type of PTK that orchestrates the regulation of proteins’ biological activities by phosphorylating the hydroxy group of serine and threonine, thus triggering a conformational change from an inactive to an active form of a protein ( Avendaño and Menéndez, 2008 ). Of note, many salivary peptides/proteins could affect the same host cell population (functional redundancy), and likewise, one salivary peptide/protein could target more than one host cell population (pluripotency) ( Aounallah et al., 2020 ), and these activities could be championed by the presence of serine/threonine-protein kinase.…”
Section: Discussionmentioning
confidence: 99%
“…Protein phosphorylation is a recurring topic in medical science as the mechanism that regulates various cellular processes. Protein modification is catalysed by protein kinases that use ATP as the source of phosphate [1,2]. Protein kinases have become the aim of targeted therapy because they play a key role in proliferation, cell cycle, and cell death.…”
Section: Introductionmentioning
confidence: 99%
“…Kinase inhibitors semaxanib and orantinib bear an oxindole moiety with a substituent at the C3 position [21]. Semaxanib has reached phase III clinical trials in the treatment of advanced colorectal cancer [22]; and orantinib is in phase II clinical trials for the treatment of breast cancer and in phase III clinical trials for the treatment of hepatocellular carcinoma [23].…”
Section: Introductionmentioning
confidence: 99%